PS
GSK icon

Planned Solutions’s GSK GSK Stock Holding History

Planned Solutions’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-399
Closed -$16.3K – 319
2024
Q3 		$16.3K Buy
+399
New +$16.3K 0.01% 408
2024
Q1 		– Sell
-399
Closed -$14.8K – 268
2023
Q4 		$14.8K Buy
+399
New +$14.3K 0.01% 394
2021
Q1 		– Sell
-1,179
Closed -$54K – 198
2020
Q4 		$54K Hold
1,179
– – 0.04% 182
2020
Q3 		$55K Buy
+1,179
New +$59.1K 0.05% 136

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Planned Solutions's GSK Position: Q4 2024 in Review

Planned Solutions sold out of GSK (GSK) in Q4 2024, closing a stake of 399 shares — an estimated $16.3K sold.

Planned Solutions first reported a position in GSK in Q3 2020 and held it in 4 quarters. The position peaked at $55K in Q3 2020. 848 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

  • Planned Solutions reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
  • Planned Solutions sold 399 GSK shares in Q4 2024, an estimated $16.3K.
  • Planned Solutions first reported a position in GSK in Q3 2020 and held it in 4 quarters.
  • Planned Solutions's GSK position peaked at $55K in Q3 2020.
  • 848 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Planned Solutions's 13F filing for Q4 2024, filed 17 Jan 2025.